Metabiomics is developing Human Microbiome-Based Biomarkers and Molecular Diagnostics
Metabiomics has developed DNA Sequencing Technology that is the preferred Method of the NIH Human Microbiome Project
Click Here to find out more about our collaborative research services, partnering or investment opportunities
Featured Video: Immunology in the Gut Mucosa
By Nature Immunology in collaboration with Arkitek Studios
Metabiomics is an early stage molecular diagnostics company that is developing products and services based on advances in human microbiome metagenomic sciences.
Metabiomics has been an early innovator and leader in the development and application of microbial ecology and metagenomic sciences applied to human microbiome biomarker discovery and clinical research since 2004.
Metabiomics provides specialized DNA sequencing and metagenomic research services to support scientific and clinical research of the Human Microbiome.
Research NewsRead More
Metabiomics and Chinese Health Testing Leader Kindstar Global form Partnership to Develop a Microbiome and Next-Generation Sequencing-Based Screening Test for Colorectal Cancer
PRESS RELEASE POTOMAC FALLS, VA., May 6, 2013 —...
Metabiomics Selected to Present a Next-Generation Sequencing Cancer Diagnostics Strategy at Two Upcoming Investor Conferences
Metabiomics will describe its approach for developing a...
New Metabiomics Screening Test for Early Detection and Prevention of Colorectal Cancer Poised to Reduce Health Care Costs and Save Lives
Metabiomics Selected to Present Molecular Diagnostic...